Abstract
The public health problem of obesity has led to a growing number of bariatric surgeries. Despite its efficacy and metabolic benefits, bariatric surgery has several complications, metabolic liver disease being one of them.
Highlights
Obesity has reached worldwide epidemic proportions, and Portugal is no exception, with 59.1% of the adult Portuguese population (>20 years old) being overweight and 24.0% - obese [1]
In patients undergoing bariatric surgery, non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), and liver fibrosis are present in 61%, 36%, and 16%, respectively [3]
Weight loss is the pillar of treatment of these metabolic liver diseases, that involves lifestyle changes combined with medical or surgical treatments
Summary
Article history: Received: 10 January 2018, Accepted: 19 March 2018, Published: 21 March 2018
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
